GlycoMimetics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ACHL
Achilles Therapeutics plc |
$1.48 | $60.83 M | -0.89 | 204 |
ANTX
AN2 Therapeutics, Inc. |
$1.26 | $37.77 M | -0.73 | 22 |
ASMB
Assembly Biosciences, Inc. |
$10.01 | $75.11 M | -1.5 | 73 |
BCAB
BioAtla, Inc. |
$0.32 | $18.68 M | -0.22 | 61 |
CUE
Cue Biopharma, Inc. |
$0.77 | $47.50 M | -1.07 | 41 |
DYN
Dyne Therapeutics, Inc. |
$7.83 | $885.74 M | -2.32 | 191 |
FHTX
Foghorn Therapeutics Inc. |
$3.49 | $194.09 M | -2.21 | 112 |
IVA
Inventiva S.A. |
$3.31 | $316.06 M | -0.95 | 123 |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 |
MLYS
Mineralys Therapeutics, Inc. |
$13.52 | $877.13 M | -3.69 | 51 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 |
SPRO
Spero Therapeutics, Inc. |
$0.75 | $41.69 M | -0.59 | 32 |
TIL
Instil Bio, Inc. |
$15.25 | $99.52 M | -1.34 | 14 |
TRVI
Trevi Therapeutics, Inc. |
$6.10 | $589.76 M | -12.98 | 26 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
